Načítá se...
T315I基因突变的慢性髓性白血病临床特征及泊那替尼疗效
OBJECTIVE: To analyze the clinical features of chronic myeloid leukemia (CML) with T315 I mutation (CML-T315I) and compare the effectiveness of different treatments. METHODS: We retrospectively analyzed the clinical data and outcomes of 19 patients with CML-T315I receiving different treatments. The...
Uloženo v:
| Vydáno v: | Nan Fang Yi Ke Da Xue Xue Bao |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
南方医科大学学报编辑部
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6765683/ https://ncbi.nlm.nih.gov/pubmed/31068313 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12122/j.issn.1673-4254.2019.03.16 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|